Incidence of Acute Kidney Injury in HCV Infected Patients Receiving Direct-Acting Antivirals

Global Perspectives in Acute Kidney Injury: Egypt

“…5 The direct-acting antiviral regimen daclatasvir/sofosbuvir/ ribavirin, used for treatment of hepatitis C in Egypt, has been associated with AKI. 13 Unfortunately, no national data are available on the incidence of hepatitis C virus-induced AKI, especially nowadays after the implementation of the national presidential program to eliminate hepatitis C virus from Egypt. 14 Regarding hospital-acquired AKI, AKI increases the risk of mortality in patients in the ICU.…”